Adding Short to Left Gastric Artery Embolization for the Treatment of Obesity: Safety and Effectiveness
- 23 April 2024
- journal article
- research article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 47 (7) , 945-952
Abstract
Purpose This study assessed the safety and effectiveness of a technical modification that involves adding short gastric artery (SGA) embolization to left gastric artery (LGA) embolization. Material and Methods This retrospective single-center study analyzed twenty obese patients (median age of 53.5 (30–73)) who were not eligible for bariatric surgery and underwent bariatric embolization with 300–500-µm microspheres in addition to a lifestyle counseling program between March 2021 and July 2022. Eight patients had LGA + SGA embolization, and twelve had LGA embolization alone. The primary outcome measure was total body weight loss (TBWL) at 6 months in the SGA + LGA and the LGA-only cohorts. Safety was assessed, defined as the 30-day adverse events rate according to the SIR classification. Results The mean 6-month post-embolization TBWL in the SGA + LGA cohort was 7.3 kg (95%CI 2.1–12.4; p = .01) and 4.1 kg (95%CI 0.4–8.6; p = 0.034) in the LGA-only cohort (mean difference − 3.1 kg ± 2.8; 95%CI (− 9.1–2.8); p = .28). The mean 6-month post-embolization TBWL in the entire cohort was 5.3 kg (p < .01). The rate of complications was similar between the two groups. Conclusion Combined SGA and LGA embolization is safe and effective to treat obesity. Larger studies are needed to determine whether SGA + LGA embolization results in more significant weight loss than LGA embolization alone. Graphical AbstractKeywords
This publication has 9 references indexed in Scilit:
- Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesiaDiagnostic and Interventional Imaging, 2022
- Once-Weekly Semaglutide in Adults with Overweight or ObesityNew England Journal of Medicine, 2021
- Bariatric Embolization in the Treatment of Patients with a Body Mass Index Between 30 and 39.9 kg/m2 (Obesity Class I and II) and Metabolic Syndrome, a Pilot StudyCardioVascular and Interventional Radiology, 2021
- Transcatheter Bariatric Embolotherapy for Weight Reduction in ObesityJACC, 2020
- Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinomaEuropean Radiology, 2020
- Bariatric Embolization of Arteries for the Treatment of Obesity (BEAT Obesity) Trial: Results at 1 YearRadiology, 2019
- Bariatric Embolization of the Left Gastric Arteries for the Treatment of Obesity: 9-Month Data in 5 PatientsObesity Surgery, 2017
- Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification SystemCardioVascular and Interventional Radiology, 2017
- The clinical anatomy of the posterior gastric artery revisitedSurgical and Radiologic Anatomy, 2007